The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Adverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Cannabis use and mental health in young people: cohort study.
Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002) · BMJ · doi:10.1136/bmj.325.7374.1195 · Cited by 997
Pharmacology and effects of cannabis: A brief review
Ashton, C. H. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.101 · Cited by 934
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Cannabinoid pharmacology: the first 66 years
Pertwee, R. G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706406 · Cited by 782
Wagner, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00367-0 · Cited by 739
Iversen, L. (2003) · Brain · doi:10.1093/brain/awg143 · Cited by 732
History of cannabis as a medicine: a review
Zuardi, A. W. (2006) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462006000200015 · Cited by 730
Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
Linszen, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 656
Russo, E., & Guy, G. W. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 610
The effects of adolescent cannabis use on educational attainment: a review
Lynskey, M., & Hall, W. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.951116213.x · Cited by 571
Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis
Large, M., Sharma, S., Compton, M. T., Slade, T., & Nielssen, O. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.5 · Cited by 563
Cannabinoids in medicine: A review of their therapeutic potential
Ben Amar, M. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.02.001 · Cited by 543
Cannabis and anxiety: a critical review of the evidence
Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1048 · Cited by 509
Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2006) · Addiction · doi:10.1111/j.1360-0443.2005.01322.x · Cited by 484
Psychiatric effects of cannabis
Johns, A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 469
The Environment and Schizophrenia: The Role of Cannabis Use
Henquet, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi027 · Cited by 454
Elevated endogenous cannabinoids in schizophrenia
Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00008 · Cited by 432
Campbell, F. A., Tramèr, M. R., Carroll, D., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.13 · Cited by 423
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Zuardi, A. W. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000300015 · Cited by 421 · cited 1×
“cytokines, and both immunosuppressant and antioxidant activity.(33) Cannabidiol lacks psychoactivity and may mitigate the anxiety and paranoia THC can induce, particularly in naive users.”
BackgroundCannabinoids and the gut: New developments and emerging concepts
Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 419
Adverse effects of medical cannabinoids: a systematic review
Wang, T., Collet, J.-P., Shapiro, S., & Ware, M. A. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071178 · Cited by 357
Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence
Patton, G. C., Coffey, C., Carlin, J. B., Sawyer, S. M., & Lynskey, M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01220.x · Cited by 356
The therapeutic potential of cannabis
Baker, D., Pryce, G., Giovannoni, G., & Thompson, A. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00381-8 · Cited by 343
Cleaning up their act: The effects of marriage and cohabitation on licit and illicit drug use
Duncan, G. J., Wilkerson, B., & England, P. (2006) · Demography · doi:10.1353/dem.2006.0032 · Cited by 338
Bossong, M. G., & Niesink, R. J. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.010 · Cited by 333
Cannabis, the mind and society: the hash realities
Murray, R. M., Morrison, P. D., Henquet, C., & Forti, M. D. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2253 · Cited by 322
Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure
Schneider, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00110.x · Cited by 316
Kuepper, R., van Os, J., Lieb, R., Wittchen, H.-U., Hofler, M., & Henquet, C. (2011) · BMJ · doi:10.1136/bmj.d738 · Cited by 304
Reinarman, C., Nunberg, H., Lanthier, F., & Heddleston, T. (2011) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2011.587700 · Cited by 290
Marijuana and cannabinoid regulation of brain reward circuits
Lupica, C. R., Riegel, A. C., & Hoffman, A. F. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705931 · Cited by 289
Testing hypotheses about the relationship between cannabis use and psychosis
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00064-4 · Cited by 270
Therapeutic aspects of cannabis and cannabinoids
Robson, P. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.107 · Cited by 265
Adverse effects of cannabis on health: an update of the literature since 1996
Kalant, H. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.027 · Cited by 264
The medicinal use of cannabis in the UK: results of a nationwide survey
Ware, M. A., Adams, H., & Guy, G. W. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00271.x · Cited by 239
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
Malone, D. T., Hill, M. N., & Rubino, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00721.x · Cited by 237
Cannabis as a substitute for alcohol and other drugs
Reiman, A. (2009) · Harm Reduction Journal · doi:10.1186/1477-7517-6-35 · Cited by 235
Watson, S. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.6.547 · Cited by 226
Cannabis Use and the Course of Schizophrenia: 10-Year Follow-Up After First Hospitalization
Foti, D. J., Kotov, R., Guey, L. T., & Bromet, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09020189 · Cited by 223
Cannabinoids in health and disease
Kogan, N. M., & Mechoulam, R. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/nkogan · Cited by 222
Adverse effects of cannabis and cannabinoids
Ashton, C. H. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/83.4.637 · Cited by 214
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
Scuderi, C., Filippis, D. D., Iuvone, T., Blasio, A., Steardo, A., & Esposito, G. (2009) · Phytotherapy Research · doi:10.1002/ptr.2625 · Cited by 209
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects
Izzo, A. A., & Camilleri, M. (2008) · Gut · doi:10.1136/gut.2008.148791 · Cited by 199
Functional consequences of marijuana use in adolescents
Jacobus, J., Bava, S., Cohen-Zion, M., Mahmood, O., & Tapert, S. F. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.001 · Cited by 185
Aggarwal, P., Carter, M., Sullivan, M., ZumBrunnen, P., Morrill, P., & Mayer, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0016 · Cited by 184
Methamphetamine Abuse: A Perfect Storm of Complications
Lineberry, T. W., & Bostwick, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.1.77 · Cited by 175
Self-citationPlant, Synthetic, and Endogenous Cannabinoids in Medicine
Marzo, V. D., & Petrocellis, L. D. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.011205.135648 · Cited by 169
Prevalence and correlates of cannabis use in developed and developing countries
Hall, W., & Degenhardt, L. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32812144cc · Cited by 166
Predictors of cessation of marijuana use: an event history analysis
Chen, K. M., & Kandel, D. B. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00021-0 · Cited by 155
The endocannabinoid system and psychiatric disorders
Parolaro, D., Realini, N., Viganò, D., Guidali, C., & Rubino, T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.018 · Cited by 151
The analgesic potential of cannabinoids.
Elikottil, M., Gupta, M., & Gupta, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0034 · Cited by 141
Medicinal and Recreational Marijuana Use by Patients Infected with HIV
Furler, M. D., Einarson, T. R., Millson, M., Walmsley, S. L., & Bendayan, R. (2004) · AIDS Patient Care and STDs · doi:10.1089/108729104323038892 · Cited by 127
Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence
Cooper, Z. D., & Haney, M. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782752 · Cited by 127
Hoffmann, D. E., & Weber, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1000695 · Cited by 124
The Toxicology of Cannabis and Cannabis Prohibition
Grotenhermen, F. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790151 · Cited by 124
Grotenhermen, F. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774322111 · Cited by 121
Who is Using Cannabis as a Medicine and Why: An Exploratory Study
Ogborne, A. C., Smart, R. G., Weber, T. R., & Timney, C. B. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400245 · Cited by 120
Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
di Forti, M., Morrison, P., Butt, A., & Murray, R. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280fa838e · Cited by 120
Decreased respiratory symptoms in cannabis users who vaporize
Earleywine, M., & Barnwell, S. S. (2007) · Harm Reduction Journal · doi:10.1186/1477-7517-4-11 · Cited by 117
Early Initiation of Cannabis Use: A Cross-national European Perspective
Kokkevi, A., Gabhainn, S. N., & Spyropoulou, M. (2006) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2006.05.009 · Cited by 110
The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
Carlini, E. A. (2004) · Toxicon · doi:10.1016/j.toxicon.2004.05.009 · Cited by 108
Relief-oriented use of marijuana by teens
Bottorff, J. L., Johnson, J. L., Moffat, B. M., & Mulvogue, T. (2009) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-4-7 · Cited by 98
Robson, P. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.575778 · Cited by 93
O'connell, T., & Bou-Matar, C. B. (2007) · Harm Reduction Journal · doi:10.1186/1477-7517-4-16 · Cited by 91
Phytocannabinoids and Endocannabinoids
Fišar, Z. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902010051 · Cited by 87
Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer
Dam, N. T. V., & Earleywine, M. (2010) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2010.04.001 · Cited by 87
Heterogeneity in the composition of marijuana seized in California
Burgdorf, J. R., Kilmer, B., & Pacula, R. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.031 · Cited by 84
Basic neuroanatomy and neuropharmacology of cannabinoids
Breivogel, C. S., & Sim‐Selley, L. J. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782760 · Cited by 79
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists
Roser, P., Vollenweider, F. X., & Kawohl, W. (2008) · The World Journal of Biological Psychiatry · doi:10.3109/15622970801908047 · Cited by 78
Examining the roles of cannabinoids in pain and other therapeutic indications: a review
Turcotte, D., Dorze, J.-A. L., Esfahani, F., Frost, E. E., Gomori, A. J., & Namaka, M. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903413534 · Cited by 72
What is the mechanism whereby cannabis use increases risk of psychosis?
Luzi, S., Morrison, P. D., Powell, J. F., Forti, M. D., & Murray, R. M. (2008) · Neurotoxicity Research · doi:10.1007/bf03033802 · Cited by 70
The abuse potential of the synthetic cannabinoid nabilone
Ware, M. A., & St Arnaud‐Trempe, E. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02776.x · Cited by 66
Comorbidity: Cannabis and Complexity
Raphael, B., Wooding, S., Stevens, G. J., & Connor, J. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200505000-00004 · Cited by 58
Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum
Cohen, P. J. (2010) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2010.00519.x · Cited by 56
The challenges in developing a rational cannabis policy
Hall, W., & Lynskey, M. T. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283298f36 · Cited by 48
Medical Marijuana: The Conflict Between Scientific Evidence and Political Ideology. Part Two of Two
Cohen, P. J. (2009) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360280902900620 · Cited by 47
Reefer Madness — The Federal Response to California's Medical-Marijuana Law
Annas, G. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370621 · Cited by 45
Cannabinoid receptor ligands as potential anticancer agents – high hopes for new therapies?
Oesch, S., & Gertsch, J. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.07.0002 · Cited by 45
Cannabis and Psychosis: What is the Link?
Amar, M. B., & Potvin, S. (2007) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2007.10399871 · Cited by 44
Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists
Gerra, G., Zaimovic, A., Gerra, M. L., Ciccocioppo, R., Cippitelli, A., Serpelloni, G., & Somaini, L. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910789753521 · Cited by 40
Quinones, F. H., Haerens, M., & Christie, L. (2012) · Cited by 39
Medical Marijuana: The Conflict Between Scientific Evidence and Political Ideology. Part One of Two
Cohen, P. J. (2009) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360280902727973 · Cited by 36
The selfish brain: learning from addiction
(1997) · Choice Reviews Online · doi:10.5860/choice.34-3894 · Cited by 34
Gut feelings about the endocannabinoid system
Marzo, V. D., & Piscitelli, F. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01689.x · Cited by 29
Association between cannabis and psychiatric hospitalization
Schubart, C. D., Boks, M. P., Breetvelt, E., van Gastel, W. A., Groenwold, R. H. H., Ophoff, R. A., Sommer, I. E., & Kahn, R. S. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01640.x · Cited by 28
Managing neuropathic pain with Sativex®: a review of its pros and cons
Pérez, J., & Ribera, M. V. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1189 · Cited by 26
Marx, J. L. (2006) · Science · doi:10.1126/science.311.5759.322 · Cited by 23
Smoked Marijuana as Medicine: Not Much Future
Kalant, H. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100497 · Cited by 17
Medical marijuana: emerging applications for the management of neurologic disorders
Carter, G. T., & Ugalde, V. (2004) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2004.03.005 · Cited by 15
Cannabis and cannabis-based medicines: potential benefits and risks to health
Wilkins, M. R. (2006) · Clinical Medicine · doi:10.7861/clinmedicine.6-1-16 · Cited by 14
Medical marijuana—moving beyond the smoke
Martin, B. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09360-1 · Cited by 14
Marmor, J. B. (1998) · Europe PMC (PubMed Central) · Cited by 11
Is there a role for marijuana in medical practice?
Ware, M. A., Mg, K., & Srivastava, A. (2006) · PubMed Central · Cited by 6
Cited by
Cannabidiol in Anxiety and Sleep: A Large Case Series
Shannon, S., Lewis, N., Lee, H., & Hughes, S. (2019) · The Permanente Journal · doi:10.7812/tpp/18-041 · Cited by 432
Evaluating the public health impacts of legalizing recreational cannabis use in the United States
Hall, W., & Lynskey, M. (2016) · Addiction · doi:10.1111/add.13428 · Cited by 357
The Genetic Structure of Marijuana and Hemp
Sawler, J., Stout, J. M., Gardner, K. M., Hudson, D., Vidmar, J., Butler, L., Page, J. E., & Myles, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133292 · Cited by 322
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
Andreae, M. H., Carter, G. M., Shaparin, N., Suslov, K., Ellis, R. J., Ware, M. A., Abrams, D. I., Prasad, H., Wilsey, B., Indyk, D., et al. (2015) · The Journal of Pain · doi:10.1016/j.jpain.2015.07.009 · Cited by 266
Addictive potential of novel treatments for refractory depression and anxiety
Kolar, D. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s167538 · Cited by 37
Metadata
- Authors
- Bostwick, J. M.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 87
- Issue
- 2
- Pages
- 172-186
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2106497943
- Cited by
- 261
- References
- 97
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.